Urine lipoarabinomannan glycan in HIV-negative patients with pulmonary tuberculosis correlates with disease severity

An accurate urine test for pulmonary tuberculosis (TB), affecting 9.6 million patients worldwide, is critically needed for surveillance and treatment management. Past attempts failed to reliably detect the mycobacterial glycan antigen lipoarabinomannan (LAM), a marker of active TB, in HIV-negative,...

Descripción completa

Detalles Bibliográficos
Autores principales: Paris, Luisa, Magni, Ruben, Zaidi, Fatima, Araujo, Robyn, Saini, Neal, Harpole, Michael, Coronel, Jorge, Kirwan, Daniela E., Steinberg, Hannah, Gilman, Robert H., Petricoin, Emanuel F., Nisini, Roberto, Luchini, Alessandra, Liotta, Lance
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for the Advancement of Science 2017
Materias:
Tuberculosis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6037412/
https://www.ncbi.nlm.nih.gov/pubmed/29237757
http://dx.doi.org/10.1126/scitranslmed.aal2807

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6037412/
https://www.ncbi.nlm.nih.gov/pubmed/29237757
http://dx.doi.org/10.1126/scitranslmed.aal2807

Ejemplares similares